Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
3ml RTU -20°C 9 Counter Staining Reagent 5ml RTU RT 10 Differentiation Reagent 6ml RTU RT 11 Mounting Media 5ml RTU RT 12 Control slide (Human kidney) 1 slide RTU RT 13 Datasheet 1 copy
K ATPase alpha 1 subunit
Conjugation None Clone# Anrukinzumab Formulation 100 mM Pro-Ac 20mM Arg pH 5
CEA was originally described in bile ducts of liver as biliary glycoprotein
BRD7_HUMAN
Anti-human Siglec-3 / CD33 (LintuzumAb Biosimilar) Size:1 mg 3ml RTU -20°C 9 CounterApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Siglec 3 CD33 Target Uniprot O14793 Overview Catalog# BIO0405SM Product Name Anti human Siglec 3 CD33 (LintuzumAb Biosimilar) Specifications Conjugation None Clone# LintuzumAb Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O
US$ 39.95
US$ 33.00
US$ 74.96
US$ 150.00
US$ 302.11
US$ 36.90
US$ 164.00
US$ 75.00
